Xylem (XYL Quick QuoteXYL - Free Report) reported $2.13 billion in revenue for the quarter ended March 2026, representing a year-over-year increase of 2.7%. EPS of $1.12 for the same period compares to $1.03 a year ago.

The reported revenue compares to the Zacks Consensus Estimate of $2.11 billion, representing a surprise of +0.88%. The company delivered an EPS surprise of +2.98%, with the consensus EPS estimate being $1.09.

While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to determine their next move, some key metrics always offer a more accurate picture of a company's financial health.

Since these metrics play a crucial role in driving the top- and bottom-line numbers, comparing them with the year-ago numbers and what analysts estimated about them helps investors better project a stock's price performance.

Here is how Xylem performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:

• Revenue- Measurement & Control Solutions: $508 million versus $492.8 million estimated by five analysts on average. Compared to the year-ago quarter, this number represents a +3.7% change.
• Revenue- Applied Water: $448 million versus the five-analyst average estimate of $444.45 million. The reported number represents a year-over-year change of +3%.
• Revenue- Water Infrastructure: $603 million versus $598.82 million estimated by five analysts on average. Compared to the year-ago quarter, this number represents a +3.8% change.
• Revenue- Water Solutions and Services: $566 million compared to the $578.48 million average estimate based on five analysts. The reported number represents a change of +0.5% year over year.
• Adjusted Operating Income- Water Infrastructure: $117 million versus $114.53 million estimated by two analysts on average.
• Adjusted Operating Income- Applied Water: $79 million versus the two-analyst average estimate of $80.38 million.
• Adjusted Operating Income- Water Solutions and Services: $83 million versus the two-analyst average estimate of $81.92 million.
• Adjusted Operating Income- Corporate and other: $-20 million versus the two-analyst average estimate of $-19.95 million.
• Adjusted Operating Income- Measurement & Control Solutions: $83 million versus $81.85 million estimated by two analysts on average.

View all Key Company Metrics for Xylem here>>>

Shares of Xylem have returned +6.3% over the past month versus the Zacks S&P 500 composite's +12.8% change. The stock currently has a Zacks Rank #4 (Sell), indicating that it could underperform the broader market in the near term.